152
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORT

Adolescents’ Knowledge and Attitudes Related to Hand Eczema: A Cross-Sectional Study

, , , , , ORCID Icon, & ORCID Icon show all
Pages 1963-1967 | Received 12 May 2023, Accepted 30 Jun 2023, Published online: 27 Jul 2023
 

Abstract

Background

Hand eczema (HE) is a common inflammatory skin disease occurring in subjects of any age. Literature data on knowledge of HE in different age-groups are scarce.

Purpose

To evaluate knowledge and attitudes related to HE among adolescents.

Methods

A total of 258 high school students were invited to participate in this project. A specially designed questionnaire created on the base of previous studies was used to assess adolescents’ knowledge of HE. HE was self-reported answering the validated single question “Have you ever had hand eczema?”

Results

Data from 243 students (94.2% response rate) were obtained for final analysis. There were 117 (48.1%) females and 126 (51.9%), males with a mean age of 16.0±1.7 years. Sixty-eight students (28%) reported a personal history of HE, and 32.8% declared having knowledge of HE. More females than males (P=0.023) declared that they knew what HE was (39.3% and 26.2%, respectively). Hand cream was used on a regular basis by 49% of adolescents. Females used hand cream more frequently (P<0.001) than males. No difference in declared knowledge of HE was found between subjects with and without a personal history of hand lesions. Students declaring having adequate knowledge of HE used hand cream more commonly (P=0.045).

Conclusion

Although HE is a common disease in the general population, including adolescents, less than a third of subjects were aware of this entity. Almost half were using hand cream, but interestingly, personal history of HE did not increase the regular application of hand cream.

Ethics

The study was approved by the Ethics Committee of Wroclaw Medical University, Wrocław, Poland (KB-663/2022).

Consent

Informed written consent was obtained from the patient for the image to be included in the article.

Disclosure

Professor Jacek C Szepietowski reports personal fees from UCB, Vifor, Novartis, Sanofi-Genzyme, Leo Pharma, Pierre-Fabre, Eli-Lilly, and Janssen-Cilag outside the submitted work. The authors report no other conflicts of interest in this work.